Related Experiment Videos
Malignant phyllodes tumor of the prostate
1Department of Urology, Tokyo Medical University, Japan. shinya@tokyo-med.ac.jp
Summary
Malignant phyllodes tumor of the prostate is a rare and aggressive cancer. This eleventh reported case highlights the need for systemic chemotherapy after radiation therapy due to metastasis.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Phyllodes tumors of the prostate are exceedingly rare neoplasms.
- These tumors share histological similarities with mammary phyllodes tumors.
- Prostate phyllodes tumors are categorized as benign, borderline, or malignant.
Observation:
- This report details the eleventh documented case of malignant phyllodes tumor of the prostate globally.
- The patient received pre- and postoperative radiation therapy, marking a first for this condition.
- A minor response to radiation was observed, but metastasis ultimately occurred.
Findings:
- Malignant phyllodes tumor of the prostate demonstrates aggressive behavior.
- Radiation therapy alone may not prevent disease progression or metastasis.
- Systemic chemotherapy is recommended as adjuvant therapy for malignant cases.
Implications:
- This case underscores the aggressive nature of malignant phyllodes tumors of the prostate.
- Adjuvant systemic chemotherapy should be considered for patients diagnosed with this rare malignancy.
- Close follow-up of borderline cases is crucial due to their potential malignant transformation.